Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells

Jiang Hong Man, Bing Liang, Yue Xi Gu, Tao Zhou, Ai Ling Li, Tao Li, Bao Feng Jin, Bing Bai, Haiying Zhang, Wei Na Zhang, Wei Hua Li, Wei Li Gong, Hui Yan Li, Xue Min Zhang

Research output: Contribution to journalArticle

Abstract

Activating mutations in Ras proteins are present in about 30% of human cancers. Despite tremendous progress in the study of Ras oncogenes, many aspects of the molecular mechanisms underlying Ras-induced tumorigenesis remain unknown. Through proteomics analysis, we previously found that the protein Gankyrin, a known oncoprotein in hepatocellular carcinoma, was upregulated during Ras-mediated transformation, although the functional consequences of this were not clear. Here we present evidence that Gankyrin plays an essential role in Ras-initiated tumorigenesis in mouse and human cells. We found that the increased Gankyrin present following Ras activation increased the interaction between the RhoA GTPase and its GDP dissociation inhibitor RhoGDI, which resulted in inhibition of the RhoA effector kinase Rho-associated coiled coil-containing protein kinase (ROCK). Importantly, Gankyrin-mediated ROCK inhibition led to prolonged Akt activation, a critical step in activated Ras-induced transformation and tumorigenesis. In addition, we found that Gankyrin is highly expressed in human lung cancers that have Ras mutations and that increased Gankyrin expression is required for the constitutive activation of Akt and tumorigenesis in these lung cancers. Our findings suggest that Gankyrin is a key regulator of Ras-mediated activation of Akt through inhibition of the downstream RhoA/ROCK pathway and thus plays an essential role in Ras-induced tumorigenesis.

Original languageEnglish (US)
Pages (from-to)2829-2841
Number of pages13
JournalJournal of Clinical Investigation
Volume120
Issue number8
DOIs
StatePublished - Aug 2 2010
Externally publishedYes

Fingerprint

Carcinogenesis
rho-Associated Kinases
Lung Neoplasms
Guanine Nucleotide Dissociation Inhibitors
ras Proteins
Mutation
ras Genes
GTP Phosphohydrolases
Oncogene Proteins
Proteomics
Hepatocellular Carcinoma
Neoplasms
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells. / Man, Jiang Hong; Liang, Bing; Gu, Yue Xi; Zhou, Tao; Li, Ai Ling; Li, Tao; Jin, Bao Feng; Bai, Bing; Zhang, Haiying; Zhang, Wei Na; Li, Wei Hua; Gong, Wei Li; Li, Hui Yan; Zhang, Xue Min.

In: Journal of Clinical Investigation, Vol. 120, No. 8, 02.08.2010, p. 2829-2841.

Research output: Contribution to journalArticle

Man, JH, Liang, B, Gu, YX, Zhou, T, Li, AL, Li, T, Jin, BF, Bai, B, Zhang, H, Zhang, WN, Li, WH, Gong, WL, Li, HY & Zhang, XM 2010, 'Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells', Journal of Clinical Investigation, vol. 120, no. 8, pp. 2829-2841. https://doi.org/10.1172/JCI42542
Man, Jiang Hong ; Liang, Bing ; Gu, Yue Xi ; Zhou, Tao ; Li, Ai Ling ; Li, Tao ; Jin, Bao Feng ; Bai, Bing ; Zhang, Haiying ; Zhang, Wei Na ; Li, Wei Hua ; Gong, Wei Li ; Li, Hui Yan ; Zhang, Xue Min. / Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells. In: Journal of Clinical Investigation. 2010 ; Vol. 120, No. 8. pp. 2829-2841.
@article{60a86d210255418590156c8dead01ebe,
title = "Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells",
abstract = "Activating mutations in Ras proteins are present in about 30{\%} of human cancers. Despite tremendous progress in the study of Ras oncogenes, many aspects of the molecular mechanisms underlying Ras-induced tumorigenesis remain unknown. Through proteomics analysis, we previously found that the protein Gankyrin, a known oncoprotein in hepatocellular carcinoma, was upregulated during Ras-mediated transformation, although the functional consequences of this were not clear. Here we present evidence that Gankyrin plays an essential role in Ras-initiated tumorigenesis in mouse and human cells. We found that the increased Gankyrin present following Ras activation increased the interaction between the RhoA GTPase and its GDP dissociation inhibitor RhoGDI, which resulted in inhibition of the RhoA effector kinase Rho-associated coiled coil-containing protein kinase (ROCK). Importantly, Gankyrin-mediated ROCK inhibition led to prolonged Akt activation, a critical step in activated Ras-induced transformation and tumorigenesis. In addition, we found that Gankyrin is highly expressed in human lung cancers that have Ras mutations and that increased Gankyrin expression is required for the constitutive activation of Akt and tumorigenesis in these lung cancers. Our findings suggest that Gankyrin is a key regulator of Ras-mediated activation of Akt through inhibition of the downstream RhoA/ROCK pathway and thus plays an essential role in Ras-induced tumorigenesis.",
author = "Man, {Jiang Hong} and Bing Liang and Gu, {Yue Xi} and Tao Zhou and Li, {Ai Ling} and Tao Li and Jin, {Bao Feng} and Bing Bai and Haiying Zhang and Zhang, {Wei Na} and Li, {Wei Hua} and Gong, {Wei Li} and Li, {Hui Yan} and Zhang, {Xue Min}",
year = "2010",
month = "8",
day = "2",
doi = "10.1172/JCI42542",
language = "English (US)",
volume = "120",
pages = "2829--2841",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "8",

}

TY - JOUR

T1 - Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells

AU - Man, Jiang Hong

AU - Liang, Bing

AU - Gu, Yue Xi

AU - Zhou, Tao

AU - Li, Ai Ling

AU - Li, Tao

AU - Jin, Bao Feng

AU - Bai, Bing

AU - Zhang, Haiying

AU - Zhang, Wei Na

AU - Li, Wei Hua

AU - Gong, Wei Li

AU - Li, Hui Yan

AU - Zhang, Xue Min

PY - 2010/8/2

Y1 - 2010/8/2

N2 - Activating mutations in Ras proteins are present in about 30% of human cancers. Despite tremendous progress in the study of Ras oncogenes, many aspects of the molecular mechanisms underlying Ras-induced tumorigenesis remain unknown. Through proteomics analysis, we previously found that the protein Gankyrin, a known oncoprotein in hepatocellular carcinoma, was upregulated during Ras-mediated transformation, although the functional consequences of this were not clear. Here we present evidence that Gankyrin plays an essential role in Ras-initiated tumorigenesis in mouse and human cells. We found that the increased Gankyrin present following Ras activation increased the interaction between the RhoA GTPase and its GDP dissociation inhibitor RhoGDI, which resulted in inhibition of the RhoA effector kinase Rho-associated coiled coil-containing protein kinase (ROCK). Importantly, Gankyrin-mediated ROCK inhibition led to prolonged Akt activation, a critical step in activated Ras-induced transformation and tumorigenesis. In addition, we found that Gankyrin is highly expressed in human lung cancers that have Ras mutations and that increased Gankyrin expression is required for the constitutive activation of Akt and tumorigenesis in these lung cancers. Our findings suggest that Gankyrin is a key regulator of Ras-mediated activation of Akt through inhibition of the downstream RhoA/ROCK pathway and thus plays an essential role in Ras-induced tumorigenesis.

AB - Activating mutations in Ras proteins are present in about 30% of human cancers. Despite tremendous progress in the study of Ras oncogenes, many aspects of the molecular mechanisms underlying Ras-induced tumorigenesis remain unknown. Through proteomics analysis, we previously found that the protein Gankyrin, a known oncoprotein in hepatocellular carcinoma, was upregulated during Ras-mediated transformation, although the functional consequences of this were not clear. Here we present evidence that Gankyrin plays an essential role in Ras-initiated tumorigenesis in mouse and human cells. We found that the increased Gankyrin present following Ras activation increased the interaction between the RhoA GTPase and its GDP dissociation inhibitor RhoGDI, which resulted in inhibition of the RhoA effector kinase Rho-associated coiled coil-containing protein kinase (ROCK). Importantly, Gankyrin-mediated ROCK inhibition led to prolonged Akt activation, a critical step in activated Ras-induced transformation and tumorigenesis. In addition, we found that Gankyrin is highly expressed in human lung cancers that have Ras mutations and that increased Gankyrin expression is required for the constitutive activation of Akt and tumorigenesis in these lung cancers. Our findings suggest that Gankyrin is a key regulator of Ras-mediated activation of Akt through inhibition of the downstream RhoA/ROCK pathway and thus plays an essential role in Ras-induced tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=77955285597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955285597&partnerID=8YFLogxK

U2 - 10.1172/JCI42542

DO - 10.1172/JCI42542

M3 - Article

VL - 120

SP - 2829

EP - 2841

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 8

ER -